Home » Our Team » Cristina Rabadán-Diehl

Cristina Rabadán-Diehl

Associate Director

Cristina Rabadán-Diehl, Ph.D., an Associate Director for Clinical Trials, joined Westat after a 25-year career at the National Institutes of Health and the U.S. Department of Health and Human Services. She is a multidisciplinary scientist with experience in chronic noncommunicable diseases, global health, and health policy. Dr. Rabadán-Diehl serves as a scientific lead in several projects as well as develops partnerships with domestic and international government and nongovernment stakeholders.

Dr. Rabadán-Diehl is a professorial lecturer at the Milken Institute School of Public Health, George Washington University, where she is the director of the Global Health Diplomacy course.

Additionally, Dr. Rabadán-Diehl is a member of the Substance Abuse and Mental Health Services Administration’s National Advisory Council, which advises and makes recommendations to improve treatment, prevention, and related services for substance use and mental illness. She is also a member of the Alcohol and Other Drug Abuse Advisory Council in Montgomery County, Maryland, and an ambassador for Shatterproof, a national organization established to help reduce the stigma of opioid addiction.

A native of Madrid, Spain, Dr. Rabadán-Diehl is committed to Latino health and is a member of the Latino Caucus for Public Health, an organization that advocates for the health interests of Latinos in the United States and throughout the Americas.

Selected Publications and Presentations

  1. Frech, S., Muha, C.A., Stevens, L.M., Trimble, E.L., Brew, R., Puricelli, P.D., Luciani, S., Mohar, A., Pineros, M., Vidaurre, T., Morngan, D.R., Hawk, E.T., Schmeler, K.M., Foxhall, L.E., Rabadan-Diehl, C., Duran, D., Rendler-Garcia, M., Cazap, E.L., Santini, L., Zoss, W., Delgado, L.B., Pearlman, P.C., Given, L., Hohman, K., Baker, E.S., and Kostelecky, B. (2018). Perspectives on strengthening cancer research and control in Latin America through partnerships and diplomacy: Experience of the National Cancer Institute’s Center for Global Health. Journal of Global Oncology. doi: 10.1200/JG0-1700149
  2. Smith, R., and Rabadan-Diehl, C. (2016). Public-private partnership in countering NCD. Global Heart, 11(1), 143-144. doi: 10.1016/j.gheart.2015.12.011 PMID: 27102033
  3. Engelgau, M.M., Sampson, U.K., Rabadan-Diehl, C., Smith, R., Miranda, J., Bloomfield, G.S., Belis, D., and Narayan, K.M. (2016). Tackling NCD in LMIC: Achievements and lessons learned from the NHLBI-UnitedHealth Global Health Centers of Excellence Program. Global Heart, 11(1), 5-15. doi: 10.1016/j.gheart.2015.12.016 PMID: 27102018
  4. Rabadan-Diehl, C., and Judge, D.P. (2015). Translating cardiovascular knowledge: A global health perspective. Journal of Cardiovascular Translational Research, 8(1), 1-2. doi: 10.1007/s12265-014-9604-2 PMID: 25583535
  5. Bloomfield, G.S., Khazanie, P., Morris, A., Rabadan-Diehl, C., Benjamin, L.A., Murdoch, D., Radcliff, V.S., Velazquez, E.J., and Hicks, C. (2014). HIV and noncommunicable cardiovascular and pulmonary diseases in low- and middle-income countries in the ART era: What we know and best directions for future research. Journal of Acquired Immune Deficiency Syndromes, 67(suppl. 1), S40-S53. doi: 10.1097/QAI.0000000000000257 PMID: 25117960
  6. Owolabi, M.O., Mensah, G.A., Kimmel, P.L., Adu, D., Ramsay, M., Waddy, S.P., Ovbiagele, B., Rabadan-Diehl, C., Rasooly, R., Akarolo-Anthony, S.N., and Rotimi, C. (2014). Understanding the rise in cardiovascular diseases in Africa: Harmonising H3Africa genomic epidemiological teams and tools. Cardiovascular Journal of Africa, 25(3), 134-136. doi: 10.5830/CVJA-2014-030 PMID: 24878536
  7. Rabadan-Diehl C “Public Health Approaches to Address Substance Use Disorders: An Urgent Need of Multisectoral Engagement” in “Principles and Applications of Evidence-Based Public Health Practice”. Elsevier (in press) (expected publication end of 2022)
  8. Rabadan-Diehl, C. (2022, April). Substance Use and Stigma in the Latino Community (invited lecture presenter). Health Quality Innovation Network, Richmond, VA (on-line).
  9. Rabadan-Diehl, C (2020, April). Development of new treatments and vaccines against the SARS-COV-2 (COVID-19) (invited lecture presenter). Universidad Alcala de Henares, Department of Public Policy and Government, Madrid, Spain.
  10. Rabadan-Diehl, C. (2019, December). Implementing the results of the PARAGON clinical trial (invited panel presentation discussant). 16th Global Cardiovascular Clinical Trialists Forum, Washington, DC.


PhD, Molecular Biology and Biochemistry, University of Miami

MPH, Social and Behavioral Sciences, Johns Hopkins University

PharmD, Pharmacy and Biochemistry, Universidad Complutense (Madrid, Spain)